Mechanisms for dispensing items such as medications and medical supplies. Different mechanisms may be tailored to dispensing different kinds of items, for example medications in single dose packages, vials, syringes, or other similarly-shaped items. The dispensers may be placed in a dispensing unit that includes a lockable restock drawer and a dispense drawer into which items are dispensed by the dispensing mechanisms. The various kinds of dispensing mechanisms may be installed in the restock drawer in any workable proportion and arrangement. The dispensing mechanisms include multiple sensing technologies for tracking and inventory of items and for accurate sensing of items as they are dispensed.

A glass container is provided having a glass tube with a first end and a second end and a glass bottom closing the second end. The glass tube has a longitudinal axis and has, in a direction from the first to the second end, a top region, a junction region, a neck region, a shoulder region, and a body region. The top region is at the first end and has an outer diameter (d.sub.t), the neck region has an outer diameter (d.sub.n) with d.sub.n<d.sub.t, the body region extends to the second end and has an outer diameter (d.sub.b) with d.sub.b>d.sub.t, and the glass tube in the body region has a thickness (l.sub.b). The outer contour in a transition area between the top and neck regions is defined by a radius of curvature. The glass containers have a neck squeeze test load of at least 1100 N.

A method for improving the efficiency of a pharmaceutical filling line by running the filling line at an increased throughput rate is disclosed. The method involves using glass vials that have been strengthened and coated to reduce the coefficient of friction of the outer surface of the vials with a pharmaceutical filling line set at a rate greater than or equal to 600 vials per minute and miming in an efficiency of at least 70%. In other embodiments of the invention, the pharmaceutical filling line may also be provided with a polymer chemical coating at points of contact with the glass vials, thereby further reducing the friction between the vials and the points of contact and the effects of impact of the vials with contact points of the pharmaceutical filling line.

A sealed pharmaceutical container comprises a shoulder, a neck extending from the shoulder, and a flange extending from the neck. The flange comprises an outer surface extending from the underside surface and a contact surface extending between the outer surface and an inner surface defining an opening in the sealed pharmaceutical container. The contact surface comprises an outer peripheral edge disposed proximate to the outer surface of the flange. The sealed pharmaceutical container comprises a sealing assembly comprising a stopper extending over the contact surface of the flange and covering the opening, and a cap securing the stopper to the flange. The stopper comprises a sealing surface that is secured in contact with the contact surface of the flange to form a seal between the flange and the stopper. An outer peripheral edge of the sealing surface is disposed at or radially inward of the outer peripheral edge.

A dispenser (10) including a base (12) having a plurality of compartments (16) to hold product. The dispenser (10) further includes a lid (14) operatively associated with the base (12) and adapted to be pivotally secured to the base (12). The lid (14) includes a lid opening (24) which is adapted to be aligned with a single compartment (16) of the base (12) upon rotation of the lid (14) so that a user can access product held within the single compartment (16). The dispenser (10) includes aa sub-lid assembly (38) operatively adapted to control pivotal movement of the lid (14) relative to the base (12) thus controlling access to the compartments (16).

A holding structure for simultaneously holding containers for pharmaceutical, medical, or cosmetic compositions, includes: at least 10 receptacles for receiving the containers and being formed by side walls; a flat base frame including a central recess; first webs running parallel to each other in a first direction across the central recess; second webs running parallel to each other in a second direction across the central recess, the first webs and the second webs being arranged such that the first webs and the second webs form the side walls, each of the first webs and the second webs being formed as a continuous beam having a maximum waviness w.sub.max of 4.0 mm; and a support structure connected with the first webs and the second webs and being formed as an outer frame or a plurality of stabilizing ribs in a grid pattern.

Devices, systems, and methods used to compound a first medicament and second medicament are disclosed. The devices include a single-use or single-dose vial containing a first medicament and configured to receive an ampule containing a second medicament. The vial includes a stopper and needle configured to inject the first medicament into the ampule to compound with the second medicament.

A labeling arrangement for a multi-part container includes a sleeve-shaped cap element adapted to be coupled to and surround a closure of the container, the cap element having, relative to a longitudinal axis, first and second cap portions and a severing region. The labeling arrangement further includes a fixing label having adjacent first and second label portions. The first label portion is adapted to be attached to the second cap portion, and the second label portion is adapted to be attached to a container body of the container such that the fixation label couples the cap element to the container body, such that when the container with the labeling arrangement is opened, the cap element is separable in the severing region and at least a part of the first cap portion together with a part of the closure is removable from the second cap portion and the container body.

A pre-filled medical delivery system can have a blow-fill-seal (BFS) component and a connection assembly. The BFS component can have first and second chambers, and first and second sealed ports. Each chamber can have a respective liquid agent therein. Each sealed port can be in fluid communication with a respective one of the chambers. The connection assembly can be constructed for coupling to the BFS component. When coupled to the BFS component, the connection assembly can breach the seals of the first and second ports and provide fluid communication therebetween. The disclosed systems, when assembled, can combine the liquid agents from the first and second chambers of the BFS component and deliver the combination as a single dose of a therapeutic agent (e.g., vaccine, drug, medicament, etc.) to a patient.

A device for discharging a flowable substance, in particular for applying a medical substance, a pharmaceutical substance, a food supplement or a cosmetics, includes_an activation mechanism and a body which has a discharge opening at a first end and forms a containing space in which a frangible capsule is disposed. The capsule has two ends each having a first and a second tip and at least one of the two tips can be snapped off by actuating the activation mechanism so that the flowable substance is discharged.